Reports

Featured reports

Chronic kidney disease compendium 

The AIHW has developed core monitoring information on the prevalence, incidence, hospitalisation and deaths from CKD (including ESKD) in Australia that is updated on a regular basis on the AIHW website to ensure that the most up-to-date information and trends is easily accessible and available.

Incidence of end-stage kidney disease in Australia 1997–2013 

The incidence of end-stage kidney disease is an important indicator of the health of the Australian population and valuable for health-care planning. End-stage kidney disease usually requires kidney replacement therapy to survive—either dialysis or a kidney transplant—but not all people with ESKD receive these treatments for a variety of reasons. This report builds on an established method for estimating the incidence of end-stage kidney disease and indicates that for every new case treated with dialysis or transplant there is one that is not. The incidence rates of end-stage kidney disease are highest among those aged 75 and over.

Risk factors to health 

Health risk factors are attributes, characteristics or exposures that increase the likelihood of a person developing a disease or health disorder. Behavioural risk factors are those that individuals have the most ability to modify. Biomedical risk factors are bodily states that are often influenced by behavioural risk factors.

Incidence of insulin-treated diabetes in Australia, 2015 

This fact sheet provides the latest available national data on new cases of insulin-treated diabetes in Australia. It shows that in 2015 there were 28,775 people who began using insulin to treat their diabetes in Australia—63% had type 2 diabetes, 26% had gestational diabetes, 9% had type 1 diabetes and 2% had other forms of diabetes or their diabetes status was unknown. The fact sheet is accompanied by a dynamic data display, which provides data on insulin-treated diabetes by age at first insulin use, Indigenous status, remoteness, SEIFA and state/territory.

Diabetes and chronic kidney disease as risks for other diseases: Australian Burden of Disease Study 2011 

This report aims to provide a more comprehensive picture of the full health loss attributable to diabetes and chronic kidney disease (CKD). It quantifies the impact of diabetes and CKD on the burden of other diseases for which there is evidence of a causal association (‘linked diseases’) to estimate the indirect burden caused by these 2 diseases. It uses disease burden estimates from the Australian Burden of Disease Study 2011 and extends the standard approach for analysis of risk factors to model diabetes and CKD as risk factors. When the indirect burden due to linked diseases was taken into account, the collective burden due to diabetes was 1.9 times as high, and CKD was 2.1 times as high, as their direct burden.

Incidence of insulin-treated diabetes in Australia 2014 

Incidence of insulin-treated diabetes in Australia 2014 presents the latest available national data on new cases of insulin-treated diabetes from the 2014 National (insulin-treated) Diabetes Register. In 2014, nearly 30,000 Australians began using insulin to treat their diabetes—67% had type 2 diabetes, 23% had gestational diabetes, 9% had type 1 diabetes and 2% had other forms of diabetes. Almost 2 in 3 (63%) people diagnosed with type 1 diabetes were aged under 25, whereas almost all (93%) new cases of insulin-treated type 2 diabetes occurred in those aged over 40.

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts: Aboriginal and Torres Strait Islander people 

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts is a series of 5 reports by the National Centre for Monitoring Vascular Diseases at the Australian Institute of Health and Welfare that describe the combined burden of cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD). This report on Aboriginal and Torres Strait Islander people presents up-to-date statistics on risk factors, prevalence, hospitalisation and deaths from these 3 chronic diseases. It examines age and sex characteristics and variations by geographical location and compares these with the non-Indigenous population.

Acute kidney injury in Australia: a first national snapshot 

Acute kidney injury (AKI) is increasing in incidence globally. This report presents the first national statistical snapshot on AKI and its impact in Australia. The key findings show that AKI accounts for a considerable number of hospitalisations and deaths and further, that the burden of this condition is not equally distributed across the Australian population. These inequalities were seen in relation to all population characteristics examined, namely sex and age, remoteness of residence, socioeconomic disadvantage and Indigenous status.

Incidence of type 1 diabetes in Australia 2000–2013 

Incidence of type 1 diabetes in Australia, 2000–2013 presents the latest available national data on new cases of type 1 diabetes from Australia’s National (insulin-treated) Diabetes Register. In 2013, there were 2,323 new cases of type 1 diabetes in Australia, equating to 11 cases per 100,000 population. This rate has remained relatively stable between 2000 and 2013, fluctuating between 10 and 13 cases per 100,000 population each year.

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts: risk factors 

This report is a series of 5 reports by the National Centre for Monitoring Vascular Diseases at the Australian Institute of Health and Welfare that describe the combined burden of cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD). This report on risk factors presents the latest statistics on the behaviours and characteristics that increase the likelihood of a person developing these chronic diseases. It also describes risk factors among people who already have CVD, diabetes or CKD. It examines age and sex characteristics and variations across population groups, including by geographical location and socioeconomic disadvantage.

Cardiovascular disease, diabetes and chronic kidney disease: Australian facts: morbidity—hospital care 

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts is a series of 5 reports by the National Centre for Monitoring Vascular Diseases at the Australian Institute of Health and Welfare that describes the combined burden of cardiovascular disease (including coronary heart disease and stroke), diabetes and chronic kidney disease. This report on Morbidity presents up-to-date statistics as well as trends on hospitalisations from these chronic diseases. It examines age and sex characteristics, and variations across population groups, including among Aboriginal and Torres Strait Islander people, by geographical location, and by socioeconomic disadvantage.

Cardiovascular disease, diabetes and chronic kidney disease: Australian facts: prevalence and incidence 

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts is a series of 5 reports by the National Centre for Monitoring Vascular Diseases at the Australian Institute of Health and Welfare that describe the combined burden of cardiovascular disease (including coronary heart disease and stroke), diabetes and chronic kidney disease. This report on prevalence and incidence provides a comprehensive summary of the latest available data on the prevalence and incidence in the Australian population of these three chronic vascular diseases, acting alone or together. It examines age and sex characteristics and variations across population groups, by geographical location, and by socioeconomic disadvantage.

Cardiovascular disease, diabetes and chronic kidney disease: Australian facts mortality 

Cardiovascular disease, diabetes and chronic kidney disease—Australian facts is a series of 5 reports by the National Centre for Monitoring Vascular Diseases at the Australian Institute of Health and Welfare that describe the combined burden of cardiovascular disease (including coronary heart disease and stroke), diabetes and chronic kidney disease. This report on Mortality presents up-to-date statistics as well as trends on deaths from these chronic diseases. It examines age and sex characteristics, and variations across population groups, including among Aboriginal and Torres Strait Islander people, by geographical location, and by socioeconomic disadvantage.

Assessment of the coding of ESKD in deaths and hospitalisation data: a working paper 

Monitoring the impact of end-stage kidney disease (ESKD) is important in planning for future health needs of the population. This working paper uses linked data from Western Australia and New South Wales to assess the likelihood that a patient who is hospitalised with ESKD will have ESKD recorded on their death record, in order to establish whether mortality records in Australia reflect the actual disease pattern of people with ESKD. The study confirms that the ESKD codes used in the mortality data to estimate ESKD incidence are likely to underestimate the impact of ESKD—there is a high proportion of patients who are hospitalised with ESKD who do not have ESKD recorded on their death certificates.

Acute coronary syndrome: validation of the method used to monitor incidence in Australia 

Monitoring the incidence of acute coronary events is critical to assess the health and economic burden of coronary heart disease. This working paper uses linked data from Western Australia and New South Wales to assess the central assumptions underlying the proxy measure for estimating the incidence of acute coronary events, in the absence of a heart disease register. This validation study shows that the algorithm may underestimate the incidence of acute coronary events in Australia, but despite this the methodology does provide a reasonable measure of the acute coronary events in Australia.

Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020 

End-stage kidney disease (ESKD) is the most severe form of chronic kidney disease with patients usually requiring kidney replacement therapy in the form of dialysis or kidney transplantation to survive. Projections of the prevalence of treated end-stage kidney disease in Australia presents national level projections of the number of people receiving kidney replacement therapy for their ESKD for the period 2012 to 2020. This information is important for predicting the future burden of ESKD in Australia.

Incidence of insulin-treated diabetes in Australia 2000-2011 

Incidence of insulin-treated diabetes in Australia 2000–2011 presents the latest available national data on new cases of insulin-treated diabetes from Australia’s National Diabetes Register. In 2011, there were 2,367 new cases of type 1 diabetes in Australia, equating to 11 new cases per 100,000 population. This rate has remained stable over the last decade, with between 10 and 12 new cases per 100,000 population per year.

Stroke and its management in Australia: an update 

This report presents a comprehensive picture about, and the latest data on, stroke and how it is managed in Australia. It examines the impact of stroke on patients, their carers, the health system and aged care services. In particular for stroke patients, the report includes information on incidence, prevalence, hospitalisation, disability, treatment and deaths. The report also examines trends and inequalities in stroke and it's management in Australia; and makes international comparisons; and identifies data gaps.